July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Spectral and Lifetime Autofluorescence Characteristics of Soft Drusen and Hyperpigmentation in Patients with Age-Related Macular Degeneration (AMD)
Author Affiliations & Notes
  • Martin Hammer
    Dept of Ophthalmology, University Hospital Jena, Jena, Germany
  • Lynn Zweifel
    Dept of Ophthalmology, University Hospital Jena, Jena, Germany
  • Lukas Kreilkamp
    Dept of Ophthalmology, University Hospital Jena, Jena, Germany
  • Lydia Sauer
    Moran Eye Center, Univ. of Utah, Salt Lake City, Utah, United States
  • Rowena Schultz
    Dept of Ophthalmology, University Hospital Jena, Jena, Germany
  • Regine Augsten
    Dept of Ophthalmology, University Hospital Jena, Jena, Germany
  • Daniel Meller
    Dept of Ophthalmology, University Hospital Jena, Jena, Germany
  • Footnotes
    Commercial Relationships   Martin Hammer, Heidelberg Engineering GmbH (P); Lynn Zweifel, None; Lukas Kreilkamp, None; Lydia Sauer, None; Rowena Schultz, None; Regine Augsten, None; Daniel Meller, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3459. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Martin Hammer, Lynn Zweifel, Lukas Kreilkamp, Lydia Sauer, Rowena Schultz, Regine Augsten, Daniel Meller; Spectral and Lifetime Autofluorescence Characteristics of Soft Drusen and Hyperpigmentation in Patients with Age-Related Macular Degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2019;60(9):3459.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Soft drusen and retinal hyperpigmentation are among the main risk factors for progression of age-related macular degeneration (AMD). We investigated the autofluorescence (AF) lifetimes as well as spectral autofluorescence characteristics of these lesions in relation those of the retinal pigment epithelium (RPE).

Methods : 43 patients (mean age: 74.1±7.9 years) with non-exudative AMD and no geographic atrophy were included. Fundus AF from a 30° retinal field was investigated with the Heidelberg Engineering Spectralis®-based fluorescence lifetime imaging ophthalmoscope (FLIO), detecting the decay of the fluorescence over time in a short (498-560 nm; SSC) and a long (560-720; LSC) wavelength channel upon excitation with <100 ps laser pulses at 473 nm. The amplitude weighted mean fluorescence lifetime (tm) was calculated from a three-exponential approximation of the decay. The spectral ratio (sr) of fluorescence emission in SSC and LSC was calculated. Drusen and hyperpigmented areas were identified from color fundus photographs and SD-OCT images and segmented in the AF images. Fluorescence lifetimes as well as sr were obtained within the inner and outer ring of the standardized early treatment diabetic retinopathy study ETDRS-grid centered at the macula. Differences in tm and sr between RPE and drusen/hyperpigmentation were tested by using a paired t-test.

Results : There was no significant difference in tm between soft drusen and RPE (SSC: 284±54 vs. 280±57ps; LSC: 337±34 vs. 334±40 ps; N=34), however, the sr was significantly higher in drusen (0.555±0.077 vs. 0.529±0.081, p<0.0005). Hyperpigmentation showed significantly longer tm than RPE (SSC: 341±81 vs303±85ps, p<0.0005; LSC: 406±42 vs. 357±40 ps, p<0.0005; N=23) and the sr was higher (0.621±0.077 vs. 0.545±0.076, p<0.0005).

Conclusions : FLIO can be used to quantitatively characterize the fluorescence of RPE, drusen, and hyperpigmentation in AMD. While soft drusen show a green-shift of fluorescence emission, the fluorescence lifetimes from hyperpigmentation show an additional prolongation in comparison to values from the RPE. This may contribute to the generally prolonged lifetimes found in AMD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×